Despite New Launches, Teligent Sees A Disappointing Q4

Company Cuts First-Quarter Projections Due To COVID-19

Red_Arrow_Downturn
Teligent sees a drop in sales • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business